{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "SARS-CoV-2",
      "spike protein",
      "vaccines",
      "variants"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34890492",
  "DateCompleted": {
    "Year": "2022",
    "Month": "02",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "05"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "12",
        "Day": "15"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1002/jmv.27513"
    ],
    "Journal": {
      "ISSN": "1096-9071",
      "JournalIssue": {
        "Volume": "94",
        "Issue": "4",
        "PubDate": {
          "Year": "2022",
          "Month": "Apr"
        }
      },
      "Title": "Journal of medical virology",
      "ISOAbbreviation": "J Med Virol"
    },
    "ArticleTitle": "The variants of SARS-CoV-2 and the challenges of vaccines.",
    "Pagination": {
      "StartPage": "1366",
      "EndPage": "1372",
      "MedlinePgn": "1366-1372"
    },
    "Abstract": {
      "AbstractText": [
        "Since the outbreak of coronavirus disease 2019 (COVID-19), countries all over the world have suffered severe losses. It affects not only human life and health but also the economy. In response to COVID-19, countries have made tremendous efforts to vaccine development. The newly discovered variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have brought major challenges to the effectiveness and research of vaccines. This article reviews the existing literature and summarizes the main variants of the SARS-CoV-2 and its impact on vaccines, and provides new ideas for the later development of vaccines. An excellent job in developing and applying vaccines will be an important measure for epidemic prevention and control."
      ],
      "CopyrightInformation": "\u00a9 2021 Wiley Periodicals LLC."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-1630-4047"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Laboratory, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, Zhejiang, China."
          }
        ],
        "LastName": "Han",
        "ForeName": "Xiucui",
        "Initials": "X"
      },
      {
        "Identifier": [
          "0000-0002-6756-0630"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Laboratory, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, Zhejiang, China."
          }
        ],
        "LastName": "Ye",
        "ForeName": "Qing",
        "Initials": "Q"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Med Virol",
    "NlmUniqueID": "7705876",
    "ISSNLinking": "0146-6615"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    }
  ],
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "immunology"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Epidemiological Monitoring"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunogenicity, Vaccine"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Vaccine Development"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Vaccine Efficacy"
    }
  ]
}